Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Completed

Conditions studied: Clotting Disorders

In brief

The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.

Key facts

Study ID

NCT01375725

Run by

Universal Biosensors Pty Ltd

People needed

60

Starts

2010-09-01

Expected to finish

2010-09-01

Last updated by the study team

2011-06-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Are currently taking coumadin (warfarin)
• Are aged 18 years or older
• Able and willing to provide informed consent
• Can understand (read and write) English
• Required to provide a capillary sample as part of their routine medical check

You may not qualify if…

• Previously participated in this study

Where it is running

• White River Diagnostic Clinic — Batesville, Arkansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.